Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Explore ways to make money quickly and easily. Start boosting your income with simple strategies that fit your lifestyle.
28,655 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Meta Platforms faced a $119 billion market-cap drop as regulators threaten stricter data, privacy and ad rules. Analy...
BTSE Bhutan has secured an In-Principle Approval from Gelephu regulators to build a regulated crypto trading and cust...
California’s latest budget proposal includes a $100 million fund to help homeowners bridge insurance gaps and acceler...
As lawmakers push a sweeping crypto regulation bill, the former president's outspoken support for digital assets is c...
The Mortgage Bankers Association unveils a new forum focused on reverse mortgages and senior lending, signaling a coo...
A hospital stay can end with Medicare denying skilled nursing facility coverage if the stay is classified as observat...
Losing a spouse is hard, and navigating survivor benefits can feel overwhelming. This guide breaks down how survivor ...
XRP steadies near $1 after a brutal June selloff, with two technical signals hinting at a short-term rebound. Analyst...
Infrastructure software has led gains while traditional apps lag, prompting a reevaluation of winners and laggards. A...
As the 2026 COLA rises to 2.8%, investors turn to steady income stocks that more than cover the gap. A trio of picks ...
Strategy Inc. raised hundreds of millions by selling new common stock to buy bitcoin, while Michael Saylor posted a r...